• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 35 of 100
Image of a syringe injecting a coronavirus in front of an American flag.
HealthTrump wants a COVID-19 vaccine by Election Day. But will one be ready?
By Jeremy KahnSeptember 4, 2020
Steroids COVID death risk
HealthWHO says common steroids can slash death risk for the sickest coronavirus patients
By Sy MukherjeeSeptember 2, 2020
Walgreens hires John Standley, former Rite Aid CEO, to run U.S. unit
FinanceWalgreens hires John Standley, former Rite Aid CEO, to run U.S. unit
By Bloomberg and Angelica LaVitoAugust 31, 2020
Blink Health drug prices exclusive
HealthWhy an Amazon and Airbnb vet joined a digital health company that wants to slash drug prices
By Sy MukherjeeAugust 24, 2020
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
HealthDiversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By Sy MukherjeeAugust 12, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
MagazineHow reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
COVID-19 testing is helping CVS Health win new customers. But can it keep them?
RetailCOVID-19 testing is helping CVS Health win new customers. But can it keep them?
By Phil WahbaAugust 6, 2020
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
HealthJohnson & Johnson antidepressant spray approved for treating those at risk of suicide
By Cynthia Koons and BloombergAugust 3, 2020
SWITZERLAND-ECONOMY-PHARMA-ROCHE
NewslettersRoche tried to see if its arthritis drug could fight coronavirus. It didn’t work
By Sy MukherjeeJuly 29, 2020
Who should get get the COVID-19 vaccine?
CommentaryWhen rationing a coronavirus vaccine, pharma must keep these 3 ethical considerations in mind
By Mike ReaJuly 23, 2020
vaccine injections
CommentaryHow to speed up medical breakthroughs in the post-COVID world
By Paul HudsonJuly 15, 2020
Photo of Covid-19 on stock exchange graph.
FinanceWill we have a COVID-19 vaccine this year? Here’s what the prediction markets say
By Jeremy KahnJuly 15, 2020
ASCO 2020 cancer drugs
NewslettersOne nonprofit’s ambitious new innovation for rare blood cancer patients
By Sy MukherjeeJuly 14, 2020
Kathy Giusti of MMRF_CureCloud
HealthA nonprofit just announced a 23andMe-like genomic sequencing model for a rare cancer—but it’s free
By Sy MukherjeeJuly 14, 2020
Gilead remdesivir coronavirus FDA
HealthGilead says remdesivir slashes coronavirus deaths. But it’s complicated
By Sy MukherjeeJuly 10, 2020
1...
  • 33
  • 34
  • 35
  • 36
  • 37
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.